Topical clonazepam in stomatodynia: A randomised placebo-controlled study

Pain

Volumn 108, Issue 1-2, 2004, Pages 51-57

  Gremeau Richard, Christelle ^a   Woda, Alain ^a,f   Navez, Marie Louise ^b   Attal, Nadine ^c   Bouhassira, Didier ^c   Gagnieu, Marie Claude ^d   Laluque, Jean François ^e   Picard, Pascale ^a   Pionchon, Paul ^a   Tubert, Stéphanie ^a  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b Hôpital de St Etienne   (France)

^c INSERM U 987   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e CHU ^*  (France)

^f INSERM   (France)

Author keywords

Burning mouth syndrome; Clonazepam; Oro facial pain; Placebo controlled study; Stomatodynia

Indexed keywords

CLONAZEPAM;

ADULT; AGED; ARTICLE; BURNING MOUTH SYNDROME; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; EUPHORIA; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MALE; MOUTH PAIN; MULTICENTER STUDY; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SPASMOPHILIA; TREATMENT OUTCOME; XEROSTOMIA;

EID: 10744233923     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2003.12.002     Document Type: Article

References (45)

1. Basker R.M., Sturdee D.W., Davenport J.C. Patients with burning mouths: a clinical investigation of causative factors, including the climacteric and diabetes. Br Dent J. 145:1978;9-16.
2. Bergdahl J., Anneroth G., Perris H. Cogitive therapy in the treatment of patients with resistant burning louth syndrome: a controlled study. J Oral Pathol Med. 24:1995;213-215.
3. A receptors by estradiol: a clue for CNS changes occurring at menopause. Cell Mol Neurobiol. 16:1996;199-212.
4. Browning S., Hislop S., Scully C., Shirlaw P. The association between burning mouth syndrome and psychosocial disorders. Oral Surg Oral Med Oral Pathol. 64:1987;171-174.
5. Concas A., Follesa P., Barbaccia M.L., Purdy R.H., Biggio G. Physiological modulation of GABA(A) receptor plasticity by progesterone metabolites. Eur J Pharmacol. 375:1999;225-235.
6. Corda M.G., Orlandi M., Deiana A.M., Salvadori S., Giorgi O. Age-related decrease in the density of benzodiazepine recognition sites in the brain of the fresh water eel (Anguilla anguilla). Neurosci Lett. 133:1991;168-170.
7. Dalezios Y., Matsokis N. Brain benzodiazepine binding in aged rats. Neurochem Int. 32:1998;213-217.
8. Drugan R.C., Holmes P.V. Central and peripheral benzodiazepine receptors: involvement in an organism's response to physical and psychological stress. Neurosci Biobehav Rev. 15:1991;277-298.
9. Eli I., Kleinhaus M., Baht R., Littner M. Antecedents of burning mouth syndrome (glossodynia) - recent life events vs. psychopathologic aspects. J Dent Res. 73:1994;567-572.
10. Formaker B.K., Mott A.E., Frank M.E. The effects of topical anesthesia on oral burning mouth syndrome. Ann N Y Acad Sci. 30:1998;776-780.
11. Formaker B.K., Mott A.E., Frank M.E. The effects of topical anesthesia on oral burning in burning mouth syndrome. Ann N Y Acad Sci. 855:1998;776-780.
12. Forssell H., Jääskeläinen S., Tenovuo O., Hinkka S. Sensory dysfunction in burning mouth syndrome. Pain. 99:2002;41-47.
13. Gao S., Wang Y., Wang Z. Assessment of trigeminal somatosensory evoked potentials in burning mouth syndrome. Chin J Dent Res. 3:2000;40-46.
14. Gorsky M., Silverman S., Chinn H. Clinical characteristics and management outcome in the burning mouth syndrome. Oral Surg Oral Med Oral Pathol. 72:1991;192-195.
15. Gray P.A., Janczewski W.A., Mellen N., McCrimmon D.R., Feldman J.L. Normal breathing requires preBotzinger complex neurokinin-1 receptor-expressing neurons. Nat Neurosci. 4:2001;927-930.
16. Grushka M. Clinical features of burning mouth syndrome. Oral Surg Oral Med Oral Pathol. 63:1987;30-36.
17. Grushka M., Sessle B.J., Howley T.P. Psychophysical assessment of tactile, pain and thermal sensory functions in burning mouth syndrome. Pain. 28:1987;169-184.
18. Grushka M., Epstein J., Mott A. An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 86:1998;557-561.
19. Hammaren M., Hugoson A. Clinical psychiatric assessment of patients with burning mouth syndrome resisting oral treatment. Swed Dent J. 13:1989;77-88.
20. Huang W., Rothe M.J., Grant-Kels J.M. The burning mouth syndrome. J Am Acad Dermatol. 34:1996;91-98.
21. Jääskeläinen S.K., Forssel H., Tenovuo O. Abnormalities of the blink reflex in burning mouth syndrome. Pain. 73:1997;455-460.
22. Kamoun P., Frejaville J.P. Guide des Examens de Laboratoire. 1993;Flammarion, Paris.
23. Lipton J.A., Ship J.A., Larach-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the united states. J Am Dent Assoc. 124:1993;115-121.
24. Loldrup D., Langemark M., Hansen H.J., Olesen J., Bech P. Clomipramine and mianserin in chronic idiopathic pain syndrome. A placebo controlled study. Psychopharmacology (Berlin). 99:1989;1-7.
25. Luo A., Sugiyama K. Propofol combined with diazepam synergistically potentiates the GABA-activated chloride current in rat sensory neurons. Chin Med J. 113:2000;840-843.
26. Maresky L.S., van der Bijl P., Gird I. Burning mouth syndrome. Evaluation of multiple variables among 85 patients. Oral Surg Oral Med Oral Pathol. 75:1993;303-307.
27. Marin R.H., Arce A. Benzodiazepine receptors increase induced by stress and maze-learning performance in chick forebrain. Pharmacol Biochem Behav. 53:1996;581-584.
28. Merskey H., Bogduk N. Classification of chronic pain: description of chronic pain syndromes and definitions of pain terms. 2nd ed. 1994;IASP Press, Seattle, WA.
29. Pajot J., Ressot C., Ngom I., Woda A. Gonadectomy induces site-specific differences in nociception in rats. Pain. 104:2003;367-373.
30. Pisanty S., Rafaely B., Polishuk W.Z. The effect of steroid hormones on buccal mucosa of menopausal women. Oral Surg. 40:1975;346-353.
31. Pokupec-Gruden J.S., Cekic-Arambasin A., Gruden V. Psychogenic factors in the aetiology of stomatopyrosis. Coll Antropol. 24:2000;119-126.
32. Rojo L., Silvestre F.J., Bagan J.V., De Vicente T. Prevalence of psychopathology in burning mouth syndrome. A comparative study among patients with and without psychiatric disorders and controls. Oral Surg Oral Med Oral Pathol. 78:1994;312-316.
33. Sardella A., Uglietti D., Demarosi F., Lodi G., Bez C., Carrassi A. Benzydamine hydrochloride oral rinses in management of burning mouth syndrome. A clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 88:1999;683-686.
34. Savage N.W. Burning mouth syndrome: patient management. Aust Dent J. 41:1996;363-366.
35. Tammiala-Salonen T., Forssell H. Trazodone in burning mouth pain: a placebo-controlled, double-blind study. J Orofac Pain. 13:1999;83-88.
36. Van der Ploeg H.M., Van der Wal N., Eijkman M.A.J., Van der Waal I. Psychological aspects of patients with burning mouth syndrome. Oral Surg Oral Med Oral Pathol. 63:1987;664-668.
37. Van der Waal I. Le syndrome des sensations de brûlure buccale. 1993;Masson, Paris.
38. Watanabe M., Maemura K., Kanbara K., Tamayama T., Hayasaki H. GABA and GABA receptors in the central nervous system and other organs. Int Rev Cytol. 213:2002;1-47.
39. Woda A. What's new in the classification of idiopathic oro-facial pain? Pain in Europe IV; 146, EFIC, Prague. 2003.
40. Woda A., Pionchon P. A unified concept of idopathic orofacial pain: clinical features. J Orofac Pain. 13:1999;172-184.
41. Woda A., Pionchon P. A unified concept of idopathic orofacial pain: patho-physiological features. J Orofac Pain. 14:2000;196-212.
42. Woda A., Navez M., Picard P., Gremeau C., Pichard-Leandri E. A possible therapeutic solution for stomatodynia (burning mouth syndrome). J Orofac Pain. 12:1998;1-6.
43. Zakrzewska J.M. The burning mouth syndrome remains an enigma. Pain. 62:1995;253-257.
44. Zakrzewska J., Glenny A.M., Forssell H. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev. (3):2001;CD002779.
45. Zilli C., Brooke R.I., Lau C.L., Merskey H. Screening for psychiatric illness in patients with oral dysesthesia by means of the general health questionnaire twenty-eight items version (GHQ-28) and the irritability, depression and anxiety scale (IDA). Oral Surg Oral Med Oral Pathol. 67:1989;384-389.